Hui Rui Aier build on the acquisition breakup fee for consultations or record high

Pfizer is working with Al build (Allergan) on the break-up fee of about 2-3 per cent of $ 150 billion in potential acquisitions of consultations, the proportion consistent with other transactions.
If Pfizer to abandon the acquisition, it will be built in Al breakup fee paid above ratio, which indicates that the combined Pfizer believe regulatory risk facing yet reached the degree of endangering the survival of the transaction, although the US Treasury plans to tighten corporate tax upside this week The regulation, which is a key part of the acquisition plan.
Since the transaction itself will be one of the largest ever merger, therefore breakup fee will continue to be one of the highest on record.
Break-up fee is developed according to the size of the target company, one of the sources said Pfizer - Al build breakup fee of proportion compared with similar transactions may be at a lower level.
Previously the highest is Verizon (45.76,0.38,0.84%) Communication (Verizon Communications) 100 亿 dollar and Vodafone (33.71,0.13,0.39%) (Vodafone) reached the break-up fee, 2013 Verizon Communication intends to 1,300 billion acquisition of Vodafone's 45 percent stake in Verizon Wireless held.
The highest amount paid so far is the $ 4 billion breakup fee, in 2011 the American Telephone and Telegraph (33.62,0.08,0.24%) Company (AT & T) with $ 39 billion acquisition of T-Mobile US Inc's plan because of opposition from regulators failed to achieve.
The source warned that the break fee and Pfizer - Al build other aspects of the acquisition has not been finalized, the two sides still waiting for the Ministry of Finance announced that the latest provisions relating to tax inverted. Since the matter confidential, the sources requested anonymity.
Pfizer and Al build both declined to comment.
Reuters quoted sources reported Wednesday, Pfizer opened a price of $ 370-380 per share, plans to acquire El build. Al built the stock is currently trading at around $ 300, suggesting that investors are still worried about the prospect of acquisition. Al built fell 2.82 percent on Thursday, reported $ 302.05

( Bolise Co., Ltd. www.chemicalspharm.com )